Olema Pharmaceuticals, Inc. (OLMA)
7.105
-0.26
(-3.46%)
USD |
NASDAQ |
Oct 13, 14:56
Olema Pharmaceuticals Market Cap : 621.35M for Oct. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 12, 2026 | 643.65M |
| October 09, 2026 | 683.88M |
| October 08, 2026 | 683.88M |
| October 07, 2026 | 694.37M |
| October 06, 2026 | 692.62M |
| October 05, 2026 | 721.48M |
| October 02, 2026 | 719.29M |
| October 01, 2026 | 723.23M |
| September 30, 2026 | 755.59M |
| September 29, 2026 | 746.84M |
| September 28, 2026 | 752.96M |
| September 25, 2026 | 765.21M |
| September 24, 2026 | 790.57M |
| September 23, 2026 | 772.20M |
| September 22, 2026 | 843.04M |
| September 21, 2026 | 842.16M |
| September 18, 2026 | 858.78M |
| September 17, 2026 | 865.78M |
| September 16, 2026 | 850.91M |
| September 15, 2026 | 855.28M |
| September 14, 2026 | 899.88M |
| September 11, 2026 | 893.76M |
| September 10, 2026 | 934.86M |
| September 09, 2026 | 906.00M |
| September 08, 2026 | 960.66M |
| Date | Value |
|---|---|
| September 04, 2026 | 940.11M |
| September 03, 2026 | 938.36M |
| September 02, 2026 | 947.11M |
| September 01, 2026 | 923.50M |
| August 31, 2026 | 912.13M |
| August 28, 2026 | 898.13M |
| August 27, 2026 | 943.61M |
| August 26, 2026 | 948.86M |
| August 25, 2026 | 954.10M |
| August 24, 2026 | 912.13M |
| August 21, 2026 | 934.86M |
| August 20, 2026 | 953.23M |
| August 19, 2026 | 989.08M |
| August 18, 2026 | 931.37M |
| August 17, 2026 | 941.86M |
| August 14, 2026 | 929.62M |
| August 13, 2026 | 919.12M |
| August 12, 2026 | 913.00M |
| August 11, 2026 | 912.13M |
| August 10, 2026 | 1.044B |
| August 07, 2026 | 1.054B |
| August 06, 2026 | 1.032B |
| August 05, 2026 | 1.011B |
| August 04, 2026 | 1.027B |
| August 03, 2026 | 985.12M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| SELLAS Life Sciences Group, Inc. | 2.528B |
| ACADIA Pharmaceuticals, Inc. | 3.195B |
| Alnylam Pharmaceuticals, Inc. | 29.85B |
| Anika Therapeutics, Inc. | 273.95M |
| Savara, Inc. | 995.16M |
Market Cap Related Metrics
| PEG Ratio | -0.3302 |
| Price to Book Value | 1.443 |
| Price | 7.105 |
| Earnings Yield | -29.81% |
| PEGY Ratio | -0.3302 |